Published in J Gastroenterol Hepatol on June 01, 2005
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10
Factors associated with hepatitis B testing among Vietnamese Americans. J Gen Intern Med (2010) 1.33
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver (2016) 1.03
Screening for hepatocellular carcinoma: still in search for evidence based medicine? J Gastroenterol Hepatol (2006) 0.98
Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol (2009) 0.81
Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience. Maedica (Buchar) (2010) 0.81
Liver resection for hepatocellular carcinoma in a hepatitis B endemic area. World J Surg (2007) 0.81
Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World J Gastroenterol (2013) 0.79
Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. J Hepatol (2016) 0.79
Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives. Int J Mol Sci (2016) 0.75
Early finding of chest wall metastasis of hepatocellular carcinoma in a woman by fluorodeoxyglucose-positron emission tomography scan: a case report. J Med Case Rep (2011) 0.75
Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine (Baltimore) (2016) 0.75
Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study. World J Gastroenterol (2016) 0.75
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med (2013) 8.49
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med (2015) 3.13
Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med (2014) 3.10
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology (2007) 2.86
Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med (2013) 2.68
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol (2012) 2.31
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology (2014) 2.12
Increased mortality associated with after-hours and weekend admission to the intensive care unit: a retrospective analysis. Med J Aust (2011) 2.03
Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl (2006) 2.01
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C. Gastroenterology (2012) 1.96
Development and validation of the medication regimen complexity index. Ann Pharmacother (2004) 1.92
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. Hepatology (2011) 1.89
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis. Hepatology (2010) 1.66
A multicenter, randomized controlled trial comparing early nasojejunal with nasogastric nutrition in critical illness. Crit Care Med (2012) 1.57
Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3',5'-cyclic adenosine 5'-monophosphate induction of the PDE4B2 variant. Endocrinology (2007) 1.55
Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major. Am J Gastroenterol (2002) 1.45
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3. Gastroenterology (2010) 1.38
Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med (2013) 1.37
Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol (2006) 1.31
Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol (2005) 1.26
Nontraumatic spinal cord injury: demographic characteristics and complications. Arch Phys Med Rehabil (2002) 1.26
Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology (2004) 1.23
A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Aust J Physiother (2006) 1.18
No rest for the wounded: early ambulation after hip surgery accelerates recovery. ANZ J Surg (2006) 1.17
Age of red blood cells and mortality in the critically ill. Crit Care (2011) 1.15
D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol (2012) 1.11
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. J Hepatol (2010) 1.10
Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care (2008) 1.10
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol (2003) 1.09
Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia. J Gastroenterol Hepatol (2014) 1.02
A valid food frequency questionnaire for measuring dietary fish intake. Asia Pac J Clin Nutr (2002) 1.01
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut (2011) 1.00
Landmark survival as an end-point for trials in critically ill patients--comparison of alternative durations of follow-up: an exploratory analysis. Crit Care (2009) 1.00
Hyperoxia in the intensive care unit and outcome after out-of-hospital ventricular fibrillation cardiac arrest. Crit Care Resusc (2013) 0.99
Developmental and daily expression of the Pax4 and Pax6 homeobox genes in the rat retina: localization of Pax4 in photoreceptor cells. J Neurochem (2008) 0.99
A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome. Crit Care (2011) 0.97
Pineal function: impact of microarray analysis. Mol Cell Endocrinol (2009) 0.97
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. J Hepatol (2005) 0.96
Developmental and diurnal dynamics of Pax4 expression in the mammalian pineal gland: nocturnal down-regulation is mediated by adrenergic-cyclic adenosine 3',5'-monophosphate signaling. Endocrinology (2008) 0.95
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C. Hepatology (2008) 0.95
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience. J Gastroenterol Hepatol (2012) 0.95
Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia. Crit Care (2012) 0.94
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. J Virol (2011) 0.92
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology (2006) 0.92
Nontraumatic spinal cord injury rehabilitation: pressure ulcer patterns, prediction, and impact. Arch Phys Med Rehabil (2004) 0.92
NeuroD1: developmental expression and regulated genes in the rodent pineal gland. J Neurochem (2007) 0.90
Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease. Liver Int (2013) 0.90
Development and validation of the medication-based disease burden index. Ann Pharmacother (2006) 0.89
GB virus C: insights into co-infection. J Clin Virol (2005) 0.89
Extramedullary relapse of multiple myeloma presenting as hematemesis and melena. Nat Clin Pract Oncol (2006) 0.88
A positive response to a recruitment maneuver with PEEP titration in patients with ARDS, regardless of transient oxygen desaturation during the maneuver. J Intensive Care Med (2011) 0.88
Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. J Hepatol (2011) 0.88
Circadian genomics of the chick pineal gland in vitro. BMC Genomics (2008) 0.87
Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand J Gastroenterol (2015) 0.87
Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial. BMC Health Serv Res (2010) 0.87
GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease. J Gastroenterol Hepatol (2009) 0.84
Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy. Nephrol Dial Transplant (2004) 0.84
A comparison of 2 continuous passive motion protocols after total knee arthroplasty: a controlled and randomized study. J Arthroplasty (2005) 0.83
Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine. J Clin Virol (2004) 0.83
Global daily dynamics of the pineal transcriptome. Cell Tissue Res (2011) 0.83
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med (2015) 0.83
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Scand J Gastroenterol (2015) 0.83
Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study. BMC Health Serv Res (2010) 0.83
Scale-up of hydrophobin-assisted recombinant protein production in tobacco BY-2 suspension cells. Plant Biotechnol J (2013) 0.82
Prospective observational study of postoperative complications after percutaneous dilatational or surgical tracheostomy in critically ill patients. Crit Care Resusc (2009) 0.82
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. J Gastroenterol Hepatol (2013) 0.82
High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients. J Heart Lung Transplant (2005) 0.82
The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA. Antivir Ther (2005) 0.82
Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4). Mol Cell Endocrinol (2009) 0.82
Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc (2010) 0.81
Single blind, prospective, randomized controlled trial comparing dorsal aluminum and custom thermoplastic splints to stack splint for acute mallet finger. Arch Phys Med Rehabil (2011) 0.81
Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. J Clin Oncol (2010) 0.81
The Burns Evaluation and Mortality Study (BEAMS): predicting deaths in Australian and New Zealand burn patients admitted to intensive care with burns. J Trauma Acute Care Surg (2013) 0.81
A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. Scand J Gastroenterol (2012) 0.80
Male to male sex is associated with a high prevalence of exposure to GB virus C. J Clin Virol (2005) 0.80
Inflammation in the avian spleen: timing is everything. BMC Mol Biol (2010) 0.80
Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy. Drugs (2015) 0.80
Steroid-responsive catastrophic antiphospholipid syndrome. J Gastroenterol Hepatol (2004) 0.79
Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus. PLoS One (2013) 0.79
A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project. Ann Pharmacother (2012) 0.79
Brain tissue lactate elevations predict episodes of intracranial hypertension in patients with traumatic brain injury. J Am Coll Surg (2009) 0.79
Evaluation of the oxygenation ratio in the definition of early graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg (2005) 0.79
Non-cirrhotic portal hypertension in HIV mono-infected patients. J Gastroenterol Hepatol (2012) 0.79
Reply to: "Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection". J Hepatol (2013) 0.78
Long-stay patients in Australian and New Zealand intensive care units: demographics and outcomes. Crit Care Resusc (2007) 0.78
Stereoscopic evaluation of fetal bony structures. J Ultrasound Med (2008) 0.78
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. J Gastroenterol Hepatol (2014) 0.78
Can ICU stay be predicted accurately enough for fast-tracking cardiac surgical patients? Crit Care Resusc (2008) 0.78
Mortality prediction and outcomes among burns patients from Australian and New Zealand intensive care units. Crit Care Resusc (2010) 0.77
Stereolithographic vascular replicas from CT scans: choosing treatment strategies, teaching, and research from live patient scan data. AJNR Am J Neuroradiol (2005) 0.77
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough? Haematologica (2007) 0.77
The direct cost of managing patients with chronic hepatitis B infection in Australia. J Clin Gastroenterol (2004) 0.77